OPEC’s Ability to Rebalance Oil Market Still in Doubt

The Organization of the Petroleum Exporting Countries (OPEC) was founded in 1960 and now has 13 members as of 2017, but their ability to control the volatility of oil prices has never quite died down. On Tuesday, oil prices rose, but the market remained fragile with concerns coming from increasing U.S. crude output and decreasing demand for oil owing to preference of alternative energy that are environment friendly.

Demand for Crude Continues to Fall
Monthly reports on supply and demand from OPEC and this week’s U.S. data on crude production highlights that global crude inventories continue to fall and unless the wavering demand growth does not increment, the pattern will continue. The U.S. gasoline stocks are strong and the trend of electric vehicles is growing. In addition to that, U.S. output has grown about 10% since mid-2016 and is closing in on the output of Saudi Arabia and Russia. These are some of the factors resulting in reduced demand from a highly profitable market, hitting its lowest mark in last three years. Drop in commodity imports and weakening manufacturing activity in China is another restraint impacting the demand for crude oil.

Real Challenge to Drive Stockpiles Down Persists
According to the chief market strategist at futures brokerage AxiTrader, Greg McKenna, the biggest challenge for OPEC is to reduce the crude oil stockpiles to a level from where it sustainably rises. However, the falling demand this year is eating into the refining margins. In the physical market, barrels of North Sea crude were available at their lowest cost since 2015. Any efforts by OPEC to rebalance the market can only see the day of light if the oversupply is curtailed, which has not been the case for over two years.

Rising Geriatric Population Drives Global Tinnitus Incidence

San Francisco, California, May 09, 2017: TMR Research estimates the future of the global tinnitus market with a thorough analysis of the forces governing the market. The report, titled “Tinnitus Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” is a comprehensive take on the strengths bolstering the growth of the overall market and the restrains acting as an impediment. According to the research report, the global tinnitus market is likely to be driven by the growing pool of geriatrics across the globe. The report aims to be a trustworthy account of the milestones the global market has achieved to help the readers understand its trajectory.

Tinnitus refers to the constant ringing sound inside the ears and it is known to affect a large percentage of the population owing to age and deterioration of hearing abilities. Thus, an exponentially rising population of the aged is likely to be an instrumental factor in defining the soaring revenue of the global market. Some of the other causes that lead to tinnitus are ear infections, multiple sclerosis, oxidative stress, wax increase, emotional stress, presence of foreign substance in the ear, nasal allergies, exposure to deafening sounds, and circulatory system disorders.

The increasing awareness of the disease, improving accessibility to healthcare, and rising expenditure on healthcare have collectively influenced the global tinnitus market in positive ways. Additionally, presence of several treatments and drugs for treating tinnitus has also boosted the market growth.

From a geographic point of view, the global tinnitus market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The report states that North America held a leading position in the global market, which was closely followed by Europe. The high prevalence of tinnitus in the region and better healthcare infrastructure are expected to keep North America in the forefront. On the other hand, Asia Pacific is also expected to emerge as a promising region. The region boasts a huge population with vast and unmet medical needs. The improving economic condition of the regional market and the rising affordability of the people in Asia Pacific are projected to play an important part in the growth of this regional market.

Some of the leading players operating in the global tinnitus market are Abbott Laboratories, Inc., Autifony Therapeutics Limited, Auris Medical AG, Bayer AG, Dr. Willmar Schwabe GmbH & Co. KG, Merz Pharma GmbH & Co. KGaA, MSE Pharmazeutika GmbH, NeuroSystec Corporation, Orasi Medical, Inc., Novartis AG, Sound Pharmaceuticals, Inc., and GlaxoSmithKline PLC. The research report provides an in-depth understanding of the competitive landscape present in the overall market. Furthermore, the analysts have also described the research and development activities undertaken by these players in the global market.

Large Investments Bode Well for Drone-powered Business Solutions

San Francisco, California, May 09, 2017 : The global drone-powered business solutions market is anticipated to rope in opportunities for a tangible growth on the back of some crucial factors. According to a report compiled by TMR Research bearing the title “Drone-powered Business Solutions Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” towering investments by dominant players and unceasing technological development could bode well for a surging demand in the near future. Although there could be a few deterrents rolling back the demand in the world drone-powered business solutions market to some extent, players are expected to find handsome opportunities to rise above the odds.

The growth in the world drone-powered business solutions market could be favored by a wide scope of applications in various industries, impressive furtherance in the commercial drone sector, and formulation of regulatory and legislative framework on the part of unmanned aerial vehicles (UAVs). Multiple business opportunities are prognosticated to take birth as the demand for cost-efficient solutions and improved safety increases.

Howbeit, the advancement of the world drone-powered business solutions market could be impeded by certain factors such as exorbitant maintenance cost, repair complexities, limited battery life, and strict compliance requirements.

Nevertheless, the application of drones progressing far beyond photography and video and improvement of warfare capabilities is predicted to sideline the deterrents in the world drone-powered business solutions market. Today, an elevating count of businesses from various fields are looking to engage drones in their regular operations. Moreover, they are planning on drone-based services for creating novel operational and business models as a response to aggressively developing drone technologies.

Especially in the U.S., the demand for drone technology is envisioned to aggravate due to its critical applications such as data generation in a broad spectrum of business fields. As a result, North America could demonstrate supremacy in the international drone-powered business solutions market. In the foreseeable future, Europe is foretold to attract a whole lot of demand while riding on standardizations authorized by official bodies. For instance, the European Commission (EC) has already made its intentions clear to integrate UAVs into its aviation safety architecture and systemize unmanned aircraft safety (UAS) regulations.

Leading companies in the international drone-powered business solutions market are envisaged to consider scheduling UAV training programs for their staff and producing novel technologies as part of the focus on expanding their commercial bases. Superior players such as PrecisionHawk, DroneDeploy, senseFly Ltd., Phoenix Drone Services LLC, and 3D Robotics could gain a competitive edge over other participants in the international drone-powered business solutions market.

Alarming Rise in Incidence of Zika-related Birth Defects

San Francisco, California, May, 09, 2017: TMR Research presents a new report on the global Zika virus vaccine market for the 2017-2025 period. The report, titled “Zika Virus Vaccines Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” report serves as a useful tool for understanding the developmental aspects of global Zika virus vaccine market and its ancillary industries. It provides a detailed description of the vital market indicators and changing competitive hierarchy that are expected to have a bearing on this market for the aforementioned forecast period. Furthermore, the various market segments are studied and growth projections are presented at both regional and global level.

The growing prevalence of Zika virus infection is the primary factor driving the global Zika virus vaccine market. This, along with the increasing incidence of Zika fever is leading to the development of potent vaccines. The rising awareness about treatment option for Zika virus is furthering the market’s growth.

Zika virus infection is transferable. It can pass from an infected mother to her fetus. This results in the infant to be born with microcephaly and other birth defects. This has necessitated the development of vaccines for the prevention of Zika-related birth defects. For example, as per data from Brazilian state authorities, since 2014, more than 1,638 babies in the country were born with microcephaly. The alarming rise in Zika-related birth defects is creating a dire need for development of vaccines to address it.

In November 2016, Zika infection was freed from being an epidemic, as announced by the World Health Organization. The infection is expected to be less prevalent in the coming years, thereby limiting developmental initiatives for Zika virus infection. This, in turn, is restraining the market from realizing its full potential.

The Zika virus vaccine market can be studied with respect to the regional segments of North America, Asia Pacific, Europe, and Rest of the World. Among these, the Rest of the World regional segment is expected to be a significant market during the forecast period. The increasing patient pool suffering from Zika virus infection is the key factor driving the demand for these vaccines in this region. Brazil presently records the highest number of individuals suffering from the infection and is closely followed by Columbia and Venezuela.

The report studies the competitive landscape of the global Zika virus vaccine market at length. Being capital intensive world’s leading drug manufacturers are involved in this industry. This includes Takeda Pharmaceutical Co. Ltd., NewLink Genetics Co., GeneOne Life Science Inc., Sanofi S.A., Hawaii Biotech Inc., Immunovaccine Inc., Bharat Biotech International Ltd., Inovio Pharmaeuticals Inc., and GlaxoSmithKline Plc.